The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight. In report published in Nature Medicine,

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks of addiction.

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health outcomes. View on euronews